FDA Import Refusal 799-4395845-1/11/1 — Shilpa Pharma Lifesciences Limited
The FDA refused shipment 799-4395845-1/11/1 from Shilpa Pharma Lifesciences Limited (India) on Feb 23, 2018. The refused product falls under Drugs and Biologics — DASATINIB. Cited charges: 118,3280,75 This firm has 3 other import refusals on record.
Refusal details
- Date
- Feb 23, 2018
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62ZCB13 DASATINIB
- Charges
- 118,3280,75